Edition:
United States

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

3.03USD
3:59pm EST
Change (% chg)

$-0.01 (-0.33%)
Prev Close
$3.04
Open
$3.03
Day's High
$3.12
Day's Low
$3.01
Volume
68,968
Avg. Vol
153,456
52-wk High
$9.53
52-wk Low
$2.75

Latest Key Developments (Source: Significant Developments)

Teligent Inc Announces FDA Approval Of Betamethasone Dipropionate Lotion USP 0.05 Pct
Wednesday, 14 Feb 2018 09:31am EST 

Feb 14 (Reuters) - Teligent Inc ::TELIGENT INC ANNOUNCES FDA APPROVAL OF BETAMETHASONE DIPROPIONATE LOTION USP (AUGMENTED), 0.05%.TELIGENT INC - ‍EXPECT TO LAUNCH BETAMETHASONE DIPROPIONATE LOTION USP IN Q1 OF 2018 ​.  Full Article

TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%
Wednesday, 22 Nov 2017 08:30am EST 

Nov 22 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT INC- ‍EXPECT TO LAUNCH HYDROCORTISONE BUTYRATE LOTION 0.1%​ IN Q1 OF 2018.  Full Article

TELIGENT ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%
Tuesday, 21 Nov 2017 08:30am EST 

Nov 21 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%.TELIGENT INC- ‍EXPECT TO LAUNCH ERYTHROMYCIN TOPICAL SOLUTION USP, 2% BEFORE THE END 2017.  Full Article

Teligent announces FDA approval of betamethasone dipropionate ointment usp (augmented), 0.05%​
Friday, 10 Nov 2017 09:20am EST 

Nov 10 (Reuters) - Teligent Inc ::Announces FDA approval of betamethasone dipropionate ointment USP (augmented), 0.05%​.Expect to launch betamethasone dipropionate ointment USP (augmented), 0.05% in Q1 of 2018​.  Full Article

Teligent posts Q3 qtrly ‍loss per share $0.12​
Monday, 6 Nov 2017 04:05pm EST 

Nov 6 (Reuters) - Teligent Inc :Teligent Inc announces third quarter 2017 results.Sees FY 2017 revenue $65 million to $67 million.Q3 revenue fell 15 percent to $13.7 million.Teligent Inc qtrly ‍loss per share $0.12​.Q3 earnings per share view $-0.01, revenue view $19.1 million -- Thomson Reuters I/B/E/S.Teligent Inc - ‍now anticipates gross margin of 38% to 40% for year ending december 31, 2017​.Teligent - Q3 ‍results, revised FY outlook due to knock-on effect of ANDA approval delays, increased competition in one of our largest products​.  Full Article

Teligent announces FDA approval of partnered ANDA for Desonide Lotion
Monday, 2 Oct 2017 01:38pm EDT 

Oct 2 (Reuters) - Teligent Inc ::Teligent Inc announces FDA approval of partnered ANDA for Desonide Lotion, 0.05 pct.Says Desonide Lotion was submitted under a partnered development agreement by Teligent Inc With Impax Laboratories Inc​.Says currently plan to launch Desonide Lotion in Q4 of 2017.  Full Article

Teligent Inc announces FDA approval of triamcinolone acetonide cream USP, 0.1%
Tuesday, 19 Sep 2017 08:00am EDT 

Sept 19 (Reuters) - Teligent Inc :Teligent Inc announces FDA approval of triamcinolone Acetonide Cream USP, 0.1%.Teligent inc - ‍ expect to launch triamcinolone acetonide cream USP, 0.1% in Q4 of 2017​.  Full Article

Teligent reports FDA approval of clobetasol propionate cream USP
Tuesday, 22 Aug 2017 09:47am EDT 

Aug 22 (Reuters) - Teligent Inc :Teligent Inc. Announces FDA approval of clobetasol propionate cream usp, 0.05 pct, emollient.Teligent Inc - ‍expect to launch clobetasol propionate cream usp, 0.05 pct, emollient​ in q4 of 2017.  Full Article

Teligent Q2 adjusted loss per share $0.01
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - Teligent Inc :Teligent Inc announces second quarter 2017 results.Sees FY 2017 revenue $75 million to $85 million.Q2 revenue rose 7 percent to $18.4 million.Q2 adjusted loss per share $0.01.Teligent Inc says now anticipates gross margin of 47 percent to 50 percent for year ending December 31, 2017.  Full Article

FDA approves Teligent's Erythromycin topical gel
Friday, 21 Jul 2017 08:00am EDT 

July 21 (Reuters) - Teligent Inc -:Teligent Inc announces FDA approval of erythromycin topical gel usp, 2%.Says ‍we expect to launch the product in Q3 of 2017​.  Full Article

BRIEF-Teligent Inc Announces FDA Approval Of Betamethasone Dipropionate Lotion USP 0.05 Pct

* TELIGENT INC ANNOUNCES FDA APPROVAL OF BETAMETHASONE DIPROPIONATE LOTION USP (AUGMENTED), 0.05%